Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Ichthyoses

Clinical, Biochemical, Pathogenic and Diagnostic Assessment

Elias P.M. (San Francisco, Calif.) 
Williams M.L. (San Francisco, Calif.) 
Crumrine D. (San Francisco, Calif.) 
Schmuth M. (Innsbruck) 
Cover

Chapter 4

Inherited Disorders of Corneocyte Proteins

Elias P.M. · Williams M.L. · Crumrine D. · Schmuth M.

Related Articles for ""

Elias PM, Williams ML, Crumrine D, Schmuth M (eds): Curr Probl Dermatol. Basel, Karger, 2010, vol 39, pp 98–131

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Published online: September 14, 2010
Cover Date: 2010

Number of Print Pages: 34
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9394-6 (Print)
eISBN: 978-3-8055-9395-3 (Online)


First-Page Preview
Abstract of Chapter 4

References

  1. Hohl D, Williams ML: Ichthyoses and related mendelian disorders of cornification (MEDOC). (eds) Irvine A, Hoger P, Yan A: Textbook of Pediatric Dermatology In press
  2. Di Giovanna JJ, Bale SJ: Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994;130:1026-1035
  3. Sahn EE, Weimer CE, Jr, Garen PD: Annular epider-molytic ichthyosis: a unique phenotype. J Am Acad Dermatol 1992;27:348-355
  4. Joh GY, Traupe H, Metze D, et al: A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 1997;108:357-361
  5. Sybert VP, Francis JS, Corden LD, et al: Cyclic ichthyosis with epidermolytic hyperkeratosis: a phenotype conferred by mutations in the 2B domain of keratin K1. Am J Hum Genet 1999;64:732-738
  6. Sprecher E, Ishida-Yamamoto A, Becker OM, et al: Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001;116:511-519
  7. Fritsch PO: Retinoids in psoriasis and disorders of keratinization. J Am Acad Dermatol 1992;27:S8-S14
  8. Bickenbach JR, Longley MA, Bundman DS, et al: A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation 1996;61:129-139
  9. Rothnagel JA, Dominey AM, Dempsey LD, et al: Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992;257:1128-1130
  10. Cheng J, Syder AJ, Yu QC, Letai A, Paller AS, Fuchs E: The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 1992;70:811-819
  11. Chipev CC, Korge BP, Markova N, et al: A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992;70:821-828
  12. Chipev CC, Yang JM, Di Giovanna JJ, et al: Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 1994;54:179-190
  13. Syder AJ, Yu QC, Paller AS, Giudice G, Pearson R, Fuchs E: Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis: correlation between location and disease severity. J Clin Invest 1994;93:1533-1542
  14. McLean WH, Eady RA, Dopping-Hepenstal PJ, et al: Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol 1994;102:24-30
  15. Yang JM, Nam K, Park KB, et al: A novel H1 mutation in the keratin 1 chain in epidermolytic hyperkeratosis. J Invest Dermatol 1996;107:439-441
  16. Arin MJ, Longley MA, Kuster W, et al: An asparagine to threonine substitution in the 1A domain of keratin 1: a novel mutation that causes epidermolytic hyperkeratosis. Exp Dermatol 1999;8:124-127
  17. Rothnagel JA, Fisher MP, Axtell SM, et al: A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis. Hum Mol Genet 1993;2:2147-2150
  18. Muller FB, Huber M, Kinaciyan T, et al: A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis. Hum Mol Genet 2006;15:1133-1141
  19. Terheyden P, Grimberg G, Hausser I, et al: Recessive epidermolytic hyperkeratosis caused by a previously unreported termination codon mutation in the keratin 10 gene. J Invest Dermatol 2009;129:2721-2723
  20. Nazzaro V, Ermacora E, Santucci B, Caputo R: Epidermolytic hyperkeratosis: generalized form in children from parents with systematized linear form. Br J Dermatol 1990;122:417-422
  21. Fuchs E, Cleveland DW: A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-519
  22. Miller RK, Khuon S, Goldman RD: Dynamics of keratin assembly: exogenous type I keratin rapidly associates with type II keratin in vivo. J Cell Biol 1993;122:123-135
  23. Ming ME, Daryanani HA, Roberts LP, Baden HP, Kvedar JC: Binding of keratin intermediate filaments (K10) to the cornified envelope in mouse epidermis: implications for barrier function. J Invest Dermatol 1994;103:780-784
  24. Steinert PM, Marekov LN: Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. Mol Biol Cell 1999;10:4247-4261
  25. Nemes Z, Steinert PM: Bricks and mortar of the epidermal barrier. Exp Mol Med 1999;31:5-19
  26. Steinert PM: The complexity and redundancy of epithelial barrier function. J Cell Biol 2000;151:F5-F8
  27. Anton-Lamprecht I: Genetically induced abnormalities of epidermal differentiation and ultrastructure in ichthyoses and epidermolyses: pathogenesis, heterogeneity, fetal manifestation, and prenatal diagnosis. J Invest Dermatol 1983;81:149s-156s
  28. Wilgram GF, Caulfield JB: An electron microscopic study of epidermolytic hyperkeratosis: with a special note on the keratinosome as the ‘fourth’ structural factor in the formation of the horny layer. Arch Dermatol 1966;94:127-143
  29. McGowan K, Coulombe PA: The wound repair-associated keratins 6, 16, and 17: insights into the role of intermediate filaments in specifying keratinocyte cytoarchitecture. Subcell Biochem 1998;31:173-204
  30. Omary MB, Coulombe PA, McLean WH: Intermediate filament proteins and their associated diseases. N Engl J Med 2004;351:2087-2100
  31. Mommers JM, van Rossum MM, van Erp PE, van de Kerkhof PC: Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 2000;201:15-20
  32. Reichelt J, Magin TM: Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice. J Cell Sci 2002;115:2639-2650
  33. Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Lane EB, Eady RA: Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992;99:19-26
  34. Virtanen M, Gedde-Dahl T, Jr, Mork NJ, Leigh I, Bowden PE, Vahlquist A: Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001;81:163-170
  35. Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB: The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol 1998;110:951-957
  36. Reichelt J, Bauer C, Porter R, Lane E, Magin V: Out of balance: consequences of a partial keratin 10 knockout. J Cell Sci 1997;110:2175-2186
  37. Fuchs E, Esteves RA, Coulombe PA: Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 1992;89:6906-6910
  38. Reichelt J, Bussow H, Grund C, Magin TM: Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol Biol Cell 2001;12:1557-1568
  39. Schmuth M, Gruber R, Elias PM, Williams M: Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders. Adv Dermatol 2007;23:231-256
  40. Schmuth M, Yosipovitch G, Williams ML, et al: Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 2001;117:837-847
  41. Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 1994;102:789-795
  42. Aunis D, Bader MF: The cytoskeleton as a barrier to exocytosis in secretory cells. J Exp Biol 1988;139:253-266
  43. Huber M, Rettler I, Bernasconi K, et al: Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995;267:525-528
  44. Russell LJ, Di Giovanna JJ, Rogers GR, et al: Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995;9:279-283
  45. Laiho E, Ignatius J, Mikkola H, et al: Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 1997;61:529-538
  46. Akiyama M, Takizawa Y, Kokaji T, Shimizu H: Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma. Br J Dermatol 2001;144:401-407
  47. Fischer J: Autosomal recessive congenital ichthyosis. J Invest Dermatol 2009;129:1319-1321
  48. Williams ML, Elias PM: Heterogeneity in autosomal recessive ichthyosis: clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985;121:477-488
  49. Frenk E, de Techtermann F: Self-healing collodion baby: evidence for autosomal recessive inheritance. Pediatr Dermatol 1992;9:95-97
  50. Van Gysel D, Lijnen RL, Moekti SS, de Laat PC, Oranje AP: Collodion baby: a follow-up study of 17 cases. J Eur Acad Dermatol Venereol 2002;16:472-475
  51. Vahlquist A, Bygum A, Ganemo A, et al: Genotypic and clinical spectrum of self-improving collodion ichthyosis: ALOX12B, ALOXE3, and TGM1 mutations in Scandinavian patients. J Invest Dermatol 2010;130:438-443
  52. Raghunath M, Hennies HC, Ahvazi B, et al: Self-healing collodion baby: a dynamic phenotype explained by a particular transglutaminase-1 mutation. J Invest Dermatol 2003;120:224-228
  53. Akiyama M: The pathogenesis of severe congenital ichthyosis of the neonate. J Dermatol Sci 1999;21:96-104
  54. Oji V, Traupe H: Ichthyoses: differential diagnosis and molecular genetics. Eur J Dermatol 2006;16:349-359
  55. Arita K, Jacyk WK, Wessagowit V, et al: The South African ‘bathing suit ichthyosis’ is a form of lamellar ichthyosis caused by a homozygous missense mutation, p.R315L, in transglutaminase 1. J Invest Dermatol 2007;127:490-493
  56. Aufenvenne K, Oji V, Walker T, et al: Transglutaminase- 1 and bathing suit ichthyosis: molecular analysis of gene/environment interactions. J Invest Dermatol 2009;129:2068-2071
  57. Hohl D: Cornified cell envelope. Dermatologica 1990;180:201-211
  58. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. Faseb J 1991;5:3071-3077
  59. Steinert PM, Marekov LN: The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995;270:17702-17711
  60. Rice RH, Crumrine D, Uchida Y, Gruber R, Elias PM: Structural changes in epidermal scale and appendages as indicators of defective TGM1 activity. Arch Dermatol Res 2005;297:127-133
  61. Hohl D, Huber M, Frenk E: Analysis of the cornified cell envelope in lamellar ichthyosis. Arch Dermatol 1993;129:618-624
  62. Elias PM, Schmuth M, Uchida Y, et al: Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 2002;11:248-256
  63. Choate KA, Medalie DA, Morgan JR, Khavari PA: Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996;2:1263-1267
  64. Kuramoto N, Takizawa T, Takizawa T, et al: Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest 2002;109:243-250
  65. Jeon S, Djian P, Green H: Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosis. Proc Natl Acad Sci USA 1998;95:687-690
  66. Rice RH, Crumrine D, Hohl D, Munro CS, Elias PM: Cross-linked envelopes in nail plate in lamellar ichthyosis. Br J Dermatol 2003;149:1050-1054
  67. Ghadially R, Williams ML, Hou SY, Elias PM: Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 1992;99:755-763
  68. Lavrijsen AP, Bouwstra JA, Gooris GS, Weerheim A, Bodde HE, Ponec M: Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J Invest Dermatol 1995;105:619-624
  69. Lavrijsen AP, Oestmann E, Hermans J, Boddé HE, Vermeer BJ, Ponec M: Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993;129:547-553
  70. Paige DG, Morse-Fisher N, Harper JI: Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 1994;131:23-27
  71. Schmuth M, Fluhr JW, Crumrine DC, et al: Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 2004;122:909-922
  72. Maestrini E, Korge BP, Ocana-Sierra J, et al: A mis-sense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999;8:1237-1243
  73. Camisa C, Rossana C: Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome): treatment with orally administered isotretinoin. Arch Dermatol 1984;120:1323-1328
  74. Camisa C, Hessel A, Rossana C, Parks A: Autosomal dominant keratoderma, ichthyosiform dermatosis and elevated serum beta-glucuronidase. Dermatologica 1988;177:341-347
  75. Korge BP, Ishida-Yamamoto A, Punter C, et al: Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997;109:604-610
  76. Armstrong DK, McKenna KE, Hughes AE: A novel insertional mutation in loricrin in Vohwinkel's keratoderma. J Invest Dermatol 1998;111:702-704
  77. Takahashi H, Ishida-Yamamoto A, Kishi A, Ohara K, Iizuka H: Loricrin gene mutation in a Japanese patient with Vohwinkel's syndrome. J Dermatol Sci 1999;19:44-47
  78. O'Driscoll J, Muston GC, McGrath JA, Lam HM, Ashworth J, Christiano AM: A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome. Clin Exp Dermatol 2002;27:243-246
  79. Matsumoto K, Muto M, Seki S, et al: Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby. Br J Dermatol 2001;145:657-660
  80. Maestrini E, Monaco AP, McGrath JA, et al: A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996;13:70-77
  81. Mehrel T, Hohl D, Rothnagel JA, et al: Identification of a major keratinocyte cell envelope protein, loricrin. Cell 1990;61:1103-1112
  82. Steven AC, Bisher ME, Roop DR, Steinert PM: Biosynthetic pathways of filaggrin and loricrin - two major proteins expressed by terminally differentiated epidermal keratinocytes. J Struct Biol 1990;104:150-162
  83. Hohl D, Mehrel T, Lichti U, Turner ML, Roop DR, Steinert PM: Characterization of human loricrin: structure and function of a new class of epidermal cell envelope proteins. J Biol Chem 1991;266:6626-6636
  84. Ishida-Yamamoto A: Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin. J Dermatol Sci 2003;31:3-8
  85. Suga Y, Duncan KO, Heald PW, Roop DR: A novel helix termination mutation in keratin 10 in annular epidermolytic ichthyosis, a variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 1998;111:1220-1223
  86. Koch PJ, de Viragh PA, Scharer E, et al: Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000;151:389-400
  87. Wells RS: Ichthyosis. Br Med J 1966;ii:1504-1506
  88. Okano M, Kitano Y, Yoshikawa K, Nakamura T, Matsuzawa Y, Yuasa T: X-linked ichthyosis and ichthyosis vulgaris: comparison of their clinical features based on biochemical analysis. Br J Dermatol 1988;119:777-783
  89. Cuevas-Covarrubias SA, Diaz-Zagoya JC, Rivera-Vega MR, et al: Higher prevalence of X-linked ichthyosis vs ichthyosis vulgaris in Mexico. Int J Dermatol 1999;38:555-556
  90. Fallon PG, Sasaki T, Sandilands A, et al: A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009;41:602-608
  91. Scharschmidt TC, Man MQ, Hatano Y, et al: Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009;124:496-506506.e1-6.
  92. Sandilands A, O'Regan GM, Liao H, et al: Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 2006;126:1770-1775
  93. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al: Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007;39:650-654
  94. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-446
  95. Elias PM, Hatano Y, Williams ML: Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008;121:1337-1343
  96. Elias PM, Steinhoff M: ‘Outside-to-inside’ (and now back to ‘outside’) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008;128:1067-1070
  97. Compton JG, Di Giovanna JJ, Johnston KA, Fleckman P, Bale SJ: Mapping of the associated phenotype of an absent granular layer in ichthyosis vulgaris to the epidermal differentiation complex on chromosome 1. Exp Dermatol 2002;11:518-526
  98. Zhong W, Cui B, Zhang Y, et al: Linkage analysis suggests a locus of ichthyosis vulgaris on 1q22. J Hum Genet 2003;48:390-392
  99. Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al: Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006;38:337-342
  100. Gruber R, Janecke A, Fauth C, Utermann G, Fritsch PO, Schmuth M: Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet 2007;15:179-184
  101. Nomura T, Sandilands A, Akiyama M, et al: Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007;119:434-440
  102. Presland RB: Function of filaggrin and caspase-14 in formation and maintenance of the epithelial barrier function. Dermatol Sin 2009;27:1-14
  103. Sybert VP, Dale BA, Holbrook KA: Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985;84:191-194
  104. Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T: Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996;288:442-446
  105. Sugiura H, Ebise H, Tazawa T, et al: Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 2005;152:146-149
  106. Fleckman P, Brumbaugh S: Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris. Exp Dermatol 2002;11:327-336
  107. Gan SQ, McBride OW, Idler WW, Markova N, Steinert PM: Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 1990;29:9432-9440
  108. Scharschmidt TC, List K, Grice EA, et al: Matriptase-deficient mice exhibit ichthyotic skin with a selective shift in skin microbiota. J Invest Dermatol 2009;129:2435-2442
  109. Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP: Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000;115:1072-1081
  110. Nirunsuksiri W, Zhang SH, Fleckman P: Reduced stability and bi-allelic, coequal expression of profilaggrin mRNA in keratinocytes cultured from subjects with ichthyosis vulgaris. J Invest Dermatol 1998;110:854-861
  111. Baden HP, Roth SI, Goldsmith LA, Baden SB, Lee LD: Keratohyalin protein in disorders of keratinization. J Invest Dermatol 1974;62:411-414
  112. Holbrook KA, Dale BA, Brown KS: Abnormal epidermal keratinization in the repeated epilation mutant mouse. J Cell Biol 1982;92:387-397
  113. Gruber R, Terron-Kwiatkowski A, Sandilands A, et al: Filaggrin mutations in ichthyosis vulgaris. J Invest Dermatol 2006;126:s40
  114. Gruber R, Terron-Kwiatkowski A, Sandilands A, et al: Proximal versus distal filaggrin mutations in ichthyosis vulgaris. J Invest Dermatol 2007;127:S87
  115. Kuechle MK, Thulin CD, Presland RB, Dale BA: Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J Invest Dermatol 1999;112:843-852
  116. Takahashi M, Tezuka T, Katunuma N: Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis. Arch Biochem Biophys 1996;329:123-126
  117. Pearton DJ, Dale BA, Presland RB: Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 2002;119:661-669
  118. Fleckman P, Holbrook KA, Dale BA, Sybert VP: Keratinocytes cultured from subjects with ichthyosis vulgaris are phenotypically abnormal. J Invest Dermatol 1987;88:640-645
  119. Rawlings AV, Scott IR, Harding CR Bowser PA: Stratum corneum moisturization at the molecular level. J Invest Dermatol 1994;103:731-741
  120. Scott IR, Harding CR, Barrett JG: Histidine-rich protein of the keratohyalin granules: source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum. Biochim Biophys Acta 1982;719:110-117
  121. Nachat R, Mechin MC, Takahara H, et al: Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005;124:384-393
  122. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986;115:84-92
  123. Williams ML: The ichthyoses - pathogenesis and prenatal diagnosis: a review of recent advances. Pediatr Dermatol 1983;1:1-24
  124. Rawlings AV, Harding CR: Moisturization and skin barrier function. Dermatol Ther 2004;17:(suppl 1)43-48
  125. Katagiri C, Sato J, Nomura J, Denda M: Changes in environmental humidity affect the water-holding property of the stratum corneum and its free amino acid content, and the expression of filaggrin in the epidermis of hairless mice. J Dermatol Sci 2003;31:29-35
  126. Krien P, Kermici M: Evidence for the existence of a self-regulated enzymatic process within human stratum corneum - an unexpected role for urocanic acid. J Invest Dermatol 2000;115:414-420
  127. Anton-Lamprecht I, Hofbauer M: Ultrastructural distinction of autosomal dominant ichthyosis vulgaris and X-linked recessive ichthyosis. Human-genetik 1972;15:261-264
  128. Schmuth M, Crumrine D, Presland RB, Fleckman P, Fritsch PO, Elias PM: Basis for the epidermal functional abnormalities in granular layer-absent (AGL) vs -present (PGL) ichthyosis vulgaris. J Invest Dermatol 2005;124:A72
  129. Ohman H, Vahlquist A: In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol 1994;74:375-379
  130. Hachem JP, Man MQ, Crumrine D, et al: Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005;125:510-520
  131. Demerjian M, Hachem JP, Tschachler E, et al: Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 2008;172:86-97
  132. Briot A, Deraison C, Lacroix M, et al: Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009;206:1135-1147
  133. Oji V, Seller N, Sandilands A, et al: Ichthyosis vulgaris: novel FLG mutations in the German population and high presence of CD1a+ cells in the epidermis of the atopic subgroup. Br J Dermatol 2009;160:771-781
  134. Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound omega-hydroxycer-amides in atopic dermatitis. J Invest Dermatol 2002;119:166-173
  135. Brusasco A, Tadini G, Cambiaghi S, Ermacora E, Grimalt R, Caputo R: A case of congenital reticular ichthyosiform erythroderma - ichthyosis ‘en confettis’. Dermatology 1994;188:40-45
  136. Choate K, Lu Y, Zhou J, et al: Ichthyosis en confetti is caused by dominant mutations in KRT10 and shows widespread somatic reversion via mitotic recombination. Science in press
  137. Camenzind M, Harms M, Chavaz P, Saurat JH: Confetti ichthyosis (in French). Ann Dermatol Vénéréol 1984;111:675-676
  138. Krunic AL, Palcesky D, Busbey S, Medenica M: Congenital reticular ichthyosiform erythroderma -ichthyosis variegata: a case report and review of the literature. Acta Derm Venereol 2003;83:36-39
  139. Moskowitz DG, Fowler AJ, Heyman MB, et al: Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultra-structure, epidermal permeability barrier function, and energy expenditure. J Pediatr 2004;145:82-92
  140. Hendrix JD, Jr, Patterson JW, Greer KE: Skin cancer associated with ichthyosis: the MAUIE syndrome. J Am Acad Dermatol 1997;37:1000-1002
  141. Elbaum DJ, Kurz G, MacDuff M: Increased incidence of cutaneous carcinomas in patients with congenital ichthyosis. J Am Acad Dermatol 1995;33:884-886

Article / Publication Details

Published online: September 14, 2010
Cover Date: 2010

Number of Print Pages: 34
Number of Figures: 0
Number of Tables: 0

ISBN: 978-3-8055-9394-6 (Print)
eISBN: 978-3-8055-9395-3 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.